vimarsana.com
Home
Live Updates
Dermaliq Therapeutics Signs USD 15 Million Series A Round to
Dermaliq Therapeutics Signs USD 15 Million Series A Round to
Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials
/PRNewswire/ -- Novaliq GmbH, 3E Bioventures Capital and Beijing Whale Technology Corporation Ltd. today announced the establishment of Dermaliq Therapeutics,...
Related Keywords
Beijing ,
China ,
Germany ,
Shanghai ,
United States ,
Ming Gao ,
Henan ,
Delaware ,
Heidelberg ,
Baden Wüberg ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Christian Roesky ,
Novaliq Gmb ,
Karen Liu ,
Whale Technology Corporation Ltd ,
Dermaliq Therapeutics Inc ,
Whale Technology ,
Whale Technology Corporation ,
Whale Pharmaceutical Co ,
Whale Chemistry Co ,
Gmbh Co ,
Whale Technology Co ,
Whale Pharmatech Co ,
Health Sciences ,
Novaliq Inc ,
Bioventures Capital ,
Beijing Whale Technology Corporation Ltd ,
Novaliq Gmbh ,
Beijing Whale Technology Corporation ,
Dermaliq Therapeutics ,
Intellectual Property ,
Chief Executive Officer ,
Managing Director ,
Chief Technology Officer ,
San Francisco Bay Area ,
Whale Pharmaceutical ,
Whale Chemistry ,
Whale Pharmatech ,
Whale Biotech ,
Hopp Biotech ,
Executive Officer ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Pharmaceuticals ,
Venture Capital ,
Accounting News Amp Issues ,
Clinical Trials Amp Medical Discoveries ,